Recently, several studies have demonstrated a negative association between FSH concentration and obesity, features of metabolic syndrome, an increased risk of diabetes, and atherosclerotic burden in postmenopausal women [4–7, 14]. This evidence concerns the gene BRD2 and metabolic syndrome.